1. Artificial intelligence–derived 3-Way Concentration-dependent Antagonism of Gatifloxacin, Pyrazinamide, and Rifampicin During Treatment of Pulmonary Tuberculosis. (28th November 2018) Authors: Pasipanodya, Jotam G; Smythe, Wynand; Merle, Corinne S; Olliaro, Piero L; Deshpande, Devyani; Magombedze, Gesham; McIlleron, Helen; Gumbo, Tawanda Journal: Clinical infectious diseases Issue: Volume 67(2018)Supplement 3 Page Start: S284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dosing tuberculosis drugs in young children: the road ahead. (September 2019) Authors: Pasipanodya, Jotam G; Gumbo, Tawanda Journal: Lancet Issue: Volume 3:Number 9(2019) Page Start: 590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis. (28th November 2018) Authors: Deshpande, Devyani; Pasipanodya, Jotam G; Mpagama, Stellah G; Srivastava, Shashikant; Bendet, Paula; Koeuth, Thearith; Lee, Pooi S; Heysell, Scott K; Gumbo, Tawanda Journal: Clinical infectious diseases Issue: Volume 67(2018)Supplement 3 Page Start: S317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gatifloxacin Pharmacokinetics/Pharmacodynamics–based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis. (28th November 2018) Authors: Deshpande, Devyani; Pasipanodya, Jotam G; Srivastava, Shashikant; Bendet, Paula; Koeuth, Thearith; Bhavnani, Sujata M; Ambrose, Paul G; Smythe, Wynand; McIlleron, Helen; Thwaites, Guy; Gumusboga, Mourad; Van Deun, Armand; Gumbo, Tawanda Journal: Clinical infectious diseases Issue: Volume 67(2018)Supplement 3 Page Start: S274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development. (16th February 2023) Authors: Gumbo, Tawanda; Srivastava, Shashikant; Deshpande, Devyani; Pasipanodya, Jotam G; Berg, Alexander; Romero, Klaus; Hermann, David; Hanna, Debra Journal: Journal of antimicrobial chemotherapy Issue: Volume 78:Number 4(2023) Page Start: 953 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Individualizing Tuberculosis (TB) Treatment: Are TB Programs in High Burden Settings Ready for Prime Time Therapeutic Drug Monitoring?. (3rd March 2018) Authors: Pasipanodya, Jotam G; Gumbo, Tawanda Journal: Clinical infectious diseases Issue: Volume 67:Number 5(2018) Page Start: 717 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis Programs. (24th April 2018) Authors: Zuur, Marlanka A; Pasipanodya, Jotam G; van Soolingen, Dick; van der Werf, Tjip S; Gumbo, Tawanda; Alffenaar, Jan-Willem C Journal: Clinical infectious diseases Issue: Volume 67:Number 11(2018) Page Start: 1743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis. (28th November 2018) Authors: Deshpande, Devyani; Pasipanodya, Jotam G; Mpagama, Stellah G; Bendet, Paula; Srivastava, Shashikant; Koeuth, Thearith; Lee, Pooi S; Bhavnani, Sujata M; Ambrose, Paul G; Thwaites, Guy; Heysell, Scott K; Gumbo, Tawanda Journal: Clinical infectious diseases Issue: Volume 67(2018)Supplement 3 Page Start: S293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Minocycline Immunomodulates via Sonic Hedgehog Signaling and Apoptosis and Has Direct Potency Against Drug-Resistant Tuberculosis. (28th December 2018) Authors: Deshpande, Devyani; Pasipanodya, Jotam G; Srivastava, Shashikant; Martin, Katherine R; Athale, Shruti; van Zyl, Johanna; Antiabong, John; Koeuth, Thearith; Lee, Pooi S; Dheda, Keertan; Gumbo, Tawanda Journal: Journal of infectious diseases Issue: Volume 219:Number 6(2019) Page Start: 975 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort Study. (22nd June 2022) Authors: Heysell, Scott K; Mpagama, Stellah G; Ogarkov, Oleg B; Conaway, Mark; Ahmed, Shahriar; Zhdanova, Svetlana; Pholwat, Suporn; Alshaer, Mohammad H; Chongolo, Anna M; Mujaga, Buliga; Sariko, Margaretha; Saba, Sabrina; Rahman, S M Mazidur; Uddin, Mohammad Khaja Mafij; Suzdalnitsky, Alexey; Moiseeva, E... Journal: Clinical infectious diseases Issue: Volume 76:Number 3(2023) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗